222 related articles for article (PubMed ID: 20305561)
1. Lupus nephritis: where are we now?
Lightstone L
Curr Opin Rheumatol; 2010 May; 22(3):252-6. PubMed ID: 20305561
[TBL] [Abstract][Full Text] [Related]
2. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
[TBL] [Abstract][Full Text] [Related]
3. Update on the management of lupus nephritis: let the treatment fit the patient.
Bertsias G; Boumpas DT
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
[TBL] [Abstract][Full Text] [Related]
4. New and future therapies for lupus nephritis.
Appel GB
Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
Lanata CM; Mahmood T; Fine DM; Petri M
Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
[TBL] [Abstract][Full Text] [Related]
6. Towards new avenues in the management of lupus glomerulonephritis.
Mok CC
Nat Rev Rheumatol; 2016 Apr; 12(4):221-34. PubMed ID: 26729459
[TBL] [Abstract][Full Text] [Related]
7. Exploring new territory: considering the future.
Schneider M
Lupus; 2007; 16(3):221-6. PubMed ID: 17432111
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis.
Fu J; Wang Z; Lee K; Wei C; Liu Z; Zhang M; Zhou M; Cai M; Zhang W; Chuang PY; Ma'ayan A; He JC; Liu Z
Kidney Int; 2018 Feb; 93(2):416-429. PubMed ID: 29102373
[TBL] [Abstract][Full Text] [Related]
9. New treatment strategies for proliferative lupus nephritis: keep children in mind!
Ranchin B; Fargue S
Lupus; 2007; 16(8):684-91. PubMed ID: 17711908
[TBL] [Abstract][Full Text] [Related]
10. Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy.
Camous L; Melander C; Vallet M; Squalli T; Knebelmann B; Noël LH; Fakhouri F
Am J Kidney Dis; 2008 Aug; 52(2):346-52. PubMed ID: 18572292
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome.
Melander C; Sallée M; Trolliet P; Candon S; Belenfant X; Daugas E; Rémy P; Zarrouk V; Pillebout E; Jacquot C; Boffa JJ; Karras A; Masse V; Lesavre P; Elie C; Brocheriou I; Knebelmann B; Noël LH; Fakhouri F
Clin J Am Soc Nephrol; 2009 Mar; 4(3):579-87. PubMed ID: 19261822
[TBL] [Abstract][Full Text] [Related]
12. Novel therapies of lupus nephritis.
Schieppati A; Remuzzi G
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):156-61. PubMed ID: 18277148
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
Navaneethan SD; Viswanathan G; Strippoli GF
Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001
[TBL] [Abstract][Full Text] [Related]
14. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy.
Mao Y; Yin L; Huang H; Zhou Z; Chen T; Zhou W
J Int Med Res; 2019 Jan; 47(1):105-113. PubMed ID: 30208769
[TBL] [Abstract][Full Text] [Related]
15. [Is rituximab effective for induction of remission in lupus nephritis?].
Mac-Namara M; Rada G
Medwave; 2014 Aug; 14(7):e6010. PubMed ID: 25334007
[TBL] [Abstract][Full Text] [Related]
16. Exploring new territory: the move towards individualised treatment.
Haubitz M
Lupus; 2007; 16(3):227-31. PubMed ID: 17432112
[TBL] [Abstract][Full Text] [Related]
17. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Condon MB; Ashby D; Pepper RJ; Cook HT; Levy JB; Griffith M; Cairns TD; Lightstone L
Ann Rheum Dis; 2013 Aug; 72(8):1280-6. PubMed ID: 23740227
[TBL] [Abstract][Full Text] [Related]
18. [Allergo-immunology. Clinical immunology].
Chizzolini C
Rev Med Suisse; 2012 Jan; 8(323):11-3. PubMed ID: 22303732
[TBL] [Abstract][Full Text] [Related]
19. Induction and maintenance therapy in proliferative lupus nephritis.
Ponticelli C; Glassock RJ; Moroni G
J Nephrol; 2010; 23(1):9-16. PubMed ID: 20091481
[TBL] [Abstract][Full Text] [Related]
20. Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids.
Pepper R; Griffith M; Kirwan C; Levy J; Taube D; Pusey C; Lightstone L; Cairns T
Nephrol Dial Transplant; 2009 Dec; 24(12):3717-23. PubMed ID: 19617257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
